The Cape Breton Post offers an informational from Brad Jacobs, CEO of Cape Breton Regional Hospital in Sydney, Nova Scotia, Canada. The regional hospital is providing important channels for patients to experience new options for cancer treatments. The hospital’s medical director, Dr. Elwood MacMullin notes” cancer clinical trials are the engine that drives progress in cancer treatment. The only way to find out if a new drug or treatment is better than the existing standard of care is to offer patients the opportunity to enroll in a clinical trial.”
Cape Breton Cancer Centre has become a nexus of cancer research and care options in Novia Scotia Canada. They recently raised funding a hockey tournament. The funds raised have afforded the Cape Breton Cancer Centre to hire Alexandra Bruleigh, clinical research coordinator for oncology. The Center is part of the Nova Scotia Health Authority. The Authority is a provincial health authority serving Nova Scotia Canada. It’s the largest employer in the province, with more than 23,000 employees and 2,500 physicians, 7,000 volunteers and 45 different facilities.
Ongoing Cape Breton Cancer Centre studies focus on DNA changes in cancer cells as well as the prevention of nausea and vomiting in oncology patients using a new anti-nausea drug. CBCC will grow and develop its clinical trials and research initiatives with the ultimate goal of enhancing the quality of patient care and treatment. For sponsors seeking oncology patients for clinical trials in this region of CBCC represents an important prospective strategic partner.